ANTX
AN2 Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.94
-0.50 ▼ -9.19%
🌙 3월 13일 7:48 PM ET (한국 3/14 08:48)
$4.91
-0.03 ▼ -0.61%
| Index | - | P/E | - | EPS (ttm) | -1.13 | Insider Own | 43.45% | Shs Outstand | 0.03B | Perf Week | 73.33% |
| Market Cap | 0.14B | Forward P/E | - | EPS next Y | 18.75% | Insider Trans | -0.45% | Shs Float | 0.02B | Perf Month | 349.09% |
| Enterprise Value | 0.07B | PEG | - | EPS next Q | -0.24 | Inst Own | 30.38% | Short Float | 0.38% | Perf Quarter | 318.64% |
| Income | -0.03B | P/S | - | EPS this Y | 34.88% | Inst Trans | 1.48% | Short Ratio | 0.04 | Perf Half Y | 288.98% |
| Sales | 0.00B | P/B | 2.24 | EPS next 5Y | 22.52% | ROA | -41.21% | Short Interest | 0.06M | Perf YTD | 333.33% |
| Book/sh | 2.21 | P/C | 2.19 | EPS past 3/5Y | -4.69% -41.25% | ROE | -45.91% | 52W High | -28.51% ($6.91) | Perf Year | 250.35% |
| Cash/sh | 2.26 | P/FCF | - | Sales past 3/5Y | - | ROIC | -56.29% | 52W Low | 394% ($1.00) | Perf 3Y | -42.36% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 44.59% | Gross Margin | - | Volatility(W/M) | 46.26% 21.2% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.63 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 9.33 | EPS Q/Q | 27.69% | Profit Margin | - | RSI (14) | 79.37 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 9.33 | Sales Q/Q | - | SMA20 | 120.54% ($2.24) | Beta | -1.65 | Target Price | $1 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | 211.1% ($1.59) | Rel Volume | 0.48 | Prev Close | $5.44 |
| Employees | 22 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -40.91% - | SMA200 | 292.76% ($1.26) | Avg Volume(3M) | 1.32M | Price | $4.94 |
| IPO | 2022/3/25 | Option/Short | No/Yes | Trades | 3360 | Volume | 630,443 | Change | -9.19% |
뉴스 로딩 중...